A study of two diuretic/potassium combinations in heart failure.
The effect of potassium supplements was studied in 28 patients taking long term frusemide (40-80 mg daily). Plasma potassium fell when supplements were stopped, and rose towards prior values on the potassium/frusemide combination, Diumide K. In a crossover study in 14 of these patients comparing equivalent doses of frusemide, Diumide K (frusemide 40 mg, potassium 8 mmol), bumetanide, and Burinex K (bumetanide 0.5 mg, potassium 7.7 mmol) plasma potassium was lower on frusemide than on bumetanide. On Diumide K and Burinex K plasma potassium rose significantly but did not reach the levels on prior therapy. Small doses of potassium in combined formulations seem to be effective in countering the mild hypokalaemia caused by loop diuretics.
D000328:Adult; D000368:Aged; D002034:Bumetanide / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000032:analysis; D005260:Female; D005665:Furosemide / Q000627:therapeutic use*; D006331:Heart Diseases / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood / Q000627:therapeutic use*; D011189:Potassium Chloride / Q000627:therapeutic use
C044661:Burinex K; D004232:Diuretics; D004338:Drug Combinations; D002034:Bumetanide; D011189:Potassium Chloride; D005665:Furosemide; C036072:Diumide-K continus; D011188:Potassium